Literature DB >> 30487166

Diagnosis of Human Immunodeficiency Virus Infection.

Bharat S Parekh1, Chin-Yih Ou1, Peter N Fonjungo1, Mireille B Kalou1, Erin Rottinghaus1, Adrian Puren2,3, Heather Alexander1, Mackenzie Hurlston Cox1, John N Nkengasong4.   

Abstract

HIV diagnostics have played a central role in the remarkable progress in identifying, staging, initiating, and monitoring infected individuals on life-saving antiretroviral therapy. They are also useful in surveillance and outbreak responses, allowing for assessment of disease burden and identification of vulnerable populations and transmission "hot spots," thus enabling planning, appropriate interventions, and allocation of appropriate funding. HIV diagnostics are critical in achieving epidemic control and require a hybrid of conventional laboratory-based diagnostic tests and new technologies, including point-of-care (POC) testing, to expand coverage, increase access, and positively impact patient management. In this review, we provide (i) a historical perspective on the evolution of HIV diagnostics (serologic and molecular) and their interplay with WHO normative guidelines, (ii) a description of the role of conventional and POC testing within the tiered laboratory diagnostic network, (iii) information on the evaluations and selection of appropriate diagnostics, (iv) a description of the quality management systems needed to ensure reliability of testing, and (v) strategies to increase access while reducing the time to return results to patients. Maintaining the central role of HIV diagnostics in programs requires periodic monitoring and optimization with quality assurance in order to inform adjustments or alignment to achieve epidemic control.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  CD4; HIV incidence; HIV rapid tests; dried blood spots; drug resistance; early infant diagnosis; enzyme immunoassay; point-of-care testing; quality assurance; viral load

Mesh:

Year:  2018        PMID: 30487166      PMCID: PMC6302353          DOI: 10.1128/CMR.00064-18

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  296 in total

1.  Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Executive summary. April 2002.

Authors: 
Journal:  IAPAC Mon       Date:  2002-06

2.  Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene HIV-1 genotyping assay.

Authors:  Renee Hallack; Lauren E Doherty; Judith A Wethers; Monica M Parker
Journal:  J Clin Virol       Date:  2008-02-20       Impact factor: 3.168

3.  HIV-1 incidence estimates using IgG-capture BED-enzyme immunoassay from surveillance sites of injection drug users in three cities of China.

Authors:  Yan Jiang; Minjie Wang; Mingjian Ni; Song Duan; Yulin Wang; Jigang Feng; Yao Xiao; Yonghui Dong; Dongli Wang; Mei Han; Lifen Xiang; Luoyun Ma; Quanhua Zhou
Journal:  AIDS       Date:  2007-12       Impact factor: 4.177

4.  Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment.

Authors:  Diane E Bennett; Mark Myatt; Silvia Bertagnolio; Donald Sutherland; Charles F Gilks
Journal:  Antivir Ther       Date:  2008

5.  An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing.

Authors:  Birgitte B Simen; Michael S Braverman; Isabella Abbate; Jeroen Aerssens; Yannick Bidet; Olivier Bouchez; Christian Gabriel; Jacques Izopet; Harald H Kessler; Evelyn Stelzl; Francesca Di Giallonardo; Ralph Schlapbach; Aleksander Radonic; Roger Paredes; Patricia Recordon-Pinson; James Sakwa; Elizabeth P St John; Gudrun G Schmitz-Agheguian; Karin J Metzner; Martin P Däumer
Journal:  J Virol Methods       Date:  2014-04-13       Impact factor: 2.014

6.  Calibration and validation of an oral fluid-based sensitive/less-sensitive assay to distinguish recent from established HIV-1 infections.

Authors:  Anne M Sill; Kristen Kreisel; Bethany Griffin Deeds; Craig M Wilson; Niel T Constantine; Ligia Peralta
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

7.  Scaling up HIV rapid testing in developing countries: comprehensive approach for implementing quality assurance.

Authors:  Bharat S Parekh; Mireille B Kalou; George Alemnji; Chin-Yih Ou; Guy-Michel Gershy-Damet; John N Nkengasong
Journal:  Am J Clin Pathol       Date:  2010-10       Impact factor: 2.493

8.  HIV drug resistance testing by high-multiplex "wide" sequencing on the MiSeq instrument.

Authors:  H R Lapointe; W Dong; G Q Lee; D R Bangsberg; J N Martin; A R Mocello; Y Boum; A Karakas; D Kirkby; A F Y Poon; P R Harrigan; C J Brumme
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

9.  Performance of a novel human immunodeficiency virus (HIV) type 1 total nucleic acid-based real-time PCR assay using whole blood and dried blood spots for diagnosis of HIV in infants.

Authors:  Wendy Stevens; Linda Erasmus; Matsidisho Moloi; Thabo Taleng; Somaya Sarang
Journal:  J Clin Microbiol       Date:  2008-10-15       Impact factor: 5.948

10.  Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.

Authors:  Yen T Duong; Maofeng Qiu; Anindya K De; Keisha Jackson; Trudy Dobbs; Andrea A Kim; John N Nkengasong; Bharat S Parekh
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

View more
  18 in total

1.  Comparison of HIV Incidence in the Zimbabwe Population-Based HIV Impact Assessment Survey (2015-2016) with Modeled Estimates: Progress Toward Epidemic Control.

Authors:  Elizabeth Gonese; Godfrey Musuka; Leala Ruangtragool; Avi Hakim; Bharat Parekh; Trudy Dobbs; Yen T Duong; Hetal Patel; Mutsa Mhangara; Owen Mugurungi; Munyaradzi Mapingure; Suzue Saito; Amy Herman-Roloff; Lovemore Gwanzura; Beth Tippett-Barr; Peter H Kilmarx; Jessica Justman
Journal:  AIDS Res Hum Retroviruses       Date:  2020-06-29       Impact factor: 2.205

Review 2.  Flow-FISH as a Tool for Studying Bacteria, Fungi and Viruses.

Authors:  Julian J Freen-van Heeren
Journal:  BioTech (Basel)       Date:  2021-10-11

3.  Fingerpick Blood-Based Nucleic Acid Testing on A USB Interfaced Device towards HIV self-testing.

Authors:  Tianyi Liu; Gihoon Choi; Zifan Tang; Aneesh Kshirsagar; Anthony J Politza; Weihua Guan
Journal:  Biosens Bioelectron       Date:  2022-04-08       Impact factor: 12.545

4.  Quality-of-Life (QoL) of Indonesian Children Living with HIV: The Role of Caregiver Stigma, Burden of Care, and Coping.

Authors:  Azwin Mengindra Putera; Margarita Maria Maramis
Journal:  HIV AIDS (Auckl)       Date:  2020-10-14

5.  Screening for Human Immunodeficiency Virus Infection by Use of a Fourth-Generation Antigen/Antibody Assay and Dried Blood Spots: In-Depth Analysis of Sensitivity and Performance Assessment in a Cross-Sectional Study.

Authors:  Karl Stefic; Jerome Guinard; Gilles Peytavin; Leïla Saboni; Cécile Sommen; Claire Sauvage; Florence Lot; Syria Laperche; Annie Velter; Francis Barin
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

6.  Meet Me Where I Am: An Evaluation of an HIV Patient Navigation Intervention to Increase Uptake of PrEP Among Black Men Who Have Sex with Men in the Deep South.

Authors:  Paul A Burns; Angela A Omondi; Mauda Monger; Lori Ward; Rodney Washington; Courtney E Sims Gomillia; Daniel R Bamrick-Fernandez; Chizoba Anyimukwu; Leandro A Mena
Journal:  J Racial Ethn Health Disparities       Date:  2021-01-05

7.  Myths in the laboratory diagnosis of HIV infection.

Authors:  Hongzhou Lu; Yi-Wei Tang
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

8.  How Useful is COVID-19 Antibody Testing - A Current Assessment for Oncologists.

Authors:  P A C Maple; K Sikora
Journal:  Clin Oncol (R Coll Radiol)       Date:  2020-10-13       Impact factor: 4.126

Review 9.  Country adherence to WHO recommendations to improve the quality of HIV diagnosis: a global policy review.

Authors:  Virginia A Fonner; Anita Sands; Carmen Figueroa; Rachel Baggaley; Caitlin Quinn; Muhammad S Jamil; Cheryl Johnson
Journal:  BMJ Glob Health       Date:  2020-05

Review 10.  Rapid Response to Pandemic Threats: Immunogenic Epitope Detection of Pandemic Pathogens for Diagnostics and Vaccine Development Using Peptide Microarrays.

Authors:  Kirsten Heiss; Jasmin Heidepriem; Nico Fischer; Laura K Weber; Christine Dahlke; Thomas Jaenisch; Felix F Loeffler
Journal:  J Proteome Res       Date:  2020-09-21       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.